Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer [Phase 2]
A Phase II, single-arm multicenter trial evaluating apatinib in combination with adebrelimab and an etoposide/carboplatin regimen as first-l…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating adebrelimab as maintenance therapy after concurrent chemoradiotherapy with hyperfractionated radiotherapy in limite…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: A Study on the Efficacy of Atezolizumab Combined with Chemotherapy
This document announces a clinical study evaluating atezolizumab in combination with chemotherapy for small cell lung cancer, currently recr…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab [Phase 2]
A Phase 2 trial update investigating whether thoraco-mediastinal radiotherapy interacts with maintenance atezolizumab in small cell lung can…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC [Phase 2]
This is a Phase II clinical trial evaluating Ivonescimab and Cadonilimab in combination with chemotherapy for extensive-stage small cell lun…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer [NA]
A recruiting clinical trial evaluating the combination of Adebrelimab and Apatinib as maintenance therapy for extensive-stage small cell lun…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Liposomal Irinotecan and Apatinib in ES-SCLC [Phase 2]
Phase 2 clinical trial evaluating liposomal irinotecan in combination with apatinib for extensive-stage small cell lung cancer is currently …
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer [Phase 3]
Biotheus Inc. is conducting a Phase 3 trial of PM8002 in combination with paclitaxel versus standard chemotherapy as second-line treatment f…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC [Phase 2]
A Phase 2 trial evaluating irinotecan liposome or etoposide in combination with adebrelimab and carboplatin for extensive-stage small cell l…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: The Diagnostic Value of Bronchoscopic Needle-based Confocal Laser Endomicroscopy (nCLE) As a Real-time Detection Tool for Diagnosing Peripheral Lung Cancer: a Multi-centre Randomised Controlled Trial [NA]
This clinical trial evaluates the diagnostic value of bronchoscopic needle-based confocal laser endomicroscopy (nCLE) as a real-time tool to…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance
A completed clinical trial evaluating molecular subtyping of extensive-stage small cell lung cancer and its clinical significance. The study…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma. [Phase 1, Phase 2]
A dose-escalation and expansion Phase 1/2 trial of ZG006 in neuroendocrine carcinoma and advanced small cell lung cancer is currently recrui…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC [Phase 3]
A Phase 3 trial examining Lurbinectedin alone or with Irinotecan versus Topotecan in relapsed small cell lung cancer is currently recruiting…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Cognitive Screening in Lung Cancer Patients
A clinical trial investigating cognitive screening in lung cancer patients is currently recruiting, including non-small cell and small cell …
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors [Phase 2]
This clinical trials update describes a multicenter, open-label Phase IIa study to evaluate the efficacy and safety of B1962 injections in a…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Molecular Analysis and Treatment Options of SCLC
A clinical trial at Shanghai Chest Hospital is investigating molecular analysis and treatment options for small-cell lung cancer and is curr…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin [Phase 2]
A Phase 2 trial evaluating first-line therapy for extensive-stage small cell lung cancer using a combination of trilaciclib, envafolimab, et…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer [Phase 3]
A Phase 3 global, open-label randomized trial evaluating RRx-001 with a platinum doublet in small cell lung cancer; the study is currently a…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases [NA]
This clinical trial update describes a study evaluating stereotactic radiation for patients with small cell lung cancer and 1–10 brain metas…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating toripalimab and JS004 in combination with platinum-based chemotherapy for relapsed and extensive-stage small cell…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases [Phase 2]
Phase 2 clinical trial evaluating antirotiinib hydrochloride in combination with whole brain radiotherapy for small cell lung cancer with br…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial comparing HS-20093 to Topotecan in relapsed small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Third-generation EGFR-TKI Plus Anlotinib as Maintenance for NSCLC With Small Cell Transformation After EGFR-TKI Resistance [Phase 2]
A Phase 2 trial is evaluating maintenance therapy with a third-generation EGFR-TKI plus Anlotinib for non-small cell lung cancer with small …
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
Ongoing clinical trial investigating PET-guided radiotherapy for small cell lung cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer [Phase 2]
Phase 2 clinical trial update showing JS-201 in combination with lenvatinib for small-cell lung cancer, currently recruiting.